Literature DB >> 22723012

Clinical management of in vitro fertilization with preimplantation genetic diagnosis.

Ilan Tur-Kaspa1.   

Abstract

Patients who undergo in vitro fertilization (IVF) because of preimplantation genetic diagnosis (PGD) require different clinical management than those who come in because of infertility alone. PGD adds a "fourth dimension" to the emotional aspect of a patients' assisted reproductive technology treatment. It significantly decreases the number of embryos available for transfer by 25 to 81%, and therefore ovarian stimulation for IVF with PGD should be tailored individually, taking into account patients' safety and estimated ovarian reserve. Recent studies showed that with increased number of oocytes retrieved, the higher the chance to have an embryo transfer and normal cryopreserved blastocysts. With adequate ovarian stimulation, there is no cutoff for the numbers of oocytes/embryos needed to start PGD with, especially for younger patients. Patient-friendly protocols, such as those based on gonadotropin-releasing hormone antagonist and vaginal progesterone support may be used. Elective single embryo transfer and blastocysts cryopreservation to avoid multiple pregnancies may be offered with PGD. The benefit of adding preimplantation genetic screening to IVF treatment is still controversial, and evidence-based data on 24-chromosome testing of polar bodies or trophectoderm is needed before it may be implemented into routine patient care.This review discusses the clinical management of IVF with PGD based on the best available data and my personal clinical experience as a reproductive specialist with >1000 IVF/intracytoplasmic sperm injection-PGD cycles. The information provided here will assist reproductive specialists, nurses, geneticists, genetic counselors, and embryologists to better counsel and treat couples who wish to conceive with a healthy child through IVF with PGD. It is time for PGD to be viewed as a modern modality of preventive medicine. As such, it should be incorporated into national health-care systems and be covered by medical insurance. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22723012     DOI: 10.1055/s-0032-1313910

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  8 in total

Review 1.  Preimplantation genetic diagnosis for inherited neurological disorders.

Authors:  Ilan Tur-Kaspa; Roohi Jeelani; P Murali Doraiswamy
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

2.  Are ovarian responses and the number of transferable embryos different in females and partners of male balanced translocation carriers?

Authors:  Mingyue Liu; Zhiqin Bu; Yan Liu; Jinhao Liu; Shanjun Dai
Journal:  J Assist Reprod Genet       Date:  2022-08-04       Impact factor: 3.357

Review 3.  Preimplantation genetic diagnosis (PGD) for genetic prion disorder due to F198S mutation in the PRNP gene.

Authors:  Alice Uflacker; P Murali Doraiswamy; Svetlana Rechitsky; Tricia See; Michael Geschwind; Ilan Tur-Kaspa
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

4.  A mathematical model for predicting the number of transferable blastocysts in next-generation sequencing-based preimplantation genetic testing.

Authors:  Yunni Cai; Min Ding; YuTing Zhang; Yanxin Sun; Fei Lin; Zhenyu Diao; Jianjun Zhou
Journal:  Arch Gynecol Obstet       Date:  2021-07-03       Impact factor: 2.344

5.  Clinical Considerations of Preimplantation Genetic Diagnosis for Monogenic Diseases.

Authors:  Xiaokun Hu; Jing Wang; Yubin Li; Yizi Wang; Chenhui Ding; Yanhong Zeng; Yanwen Xu; Canquan Zhou
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

6.  Outcomes of Preimplantation Genetic Testing for Single Gene Defects in a Privately Funded Period and Publicly Funded Period: A North-American Single Center Experience.

Authors:  Talya Shaulov; Li Zhang; Jin-Tae Chung; Weon-Young Son; William Buckett; Asangla Ao
Journal:  J Reprod Infertil       Date:  2020 Apr-Jun

7.  Assisted Reproductive Technology in China: Results Generated From Data Reporting System by CSRM From 2013 to 2016.

Authors:  Linli Hu; Zhiqin Bu; Guoning Huang; Haixiang Sun; Chengyan Deng; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-17       Impact factor: 5.555

8.  The First Live Birth in Lithuania After Application of Preimplantation Genetic Testing.

Authors:  Živilė Gudlevičienė; Raminta Baušytė; Evelina Dagytė; Danutė Balkelienė; Algirdas Utkus; Diana Ramašauskaitė
Journal:  Acta Med Litu       Date:  2020-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.